Xingquan Wang – Trademark Portfolio
Entity Type: 01
Xingquan Wang owns a portfolio of 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as JULBEAR, MARFOREVER, and ST NOVAELLE. Of these, 3 are registered. The portfolio spans 4 Nice Classification classes, led by Class 3 (Cosmetics & Cleaning) and Class 14 (Jewelry). Headquartered in Hefei, Anhui.
Rm. 204, Bldg. 18, Lvyiju,
No. 718, Dongzhi Rd., Shushan Dist.,
Hefei, Anhui 230022 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xingquan Wang's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Precious metals and their alloys; jewellery, precious stones; horological instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Xingquan Wang have?
Xingquan Wang has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Xingquan Wang file in?
Xingquan Wang files trademarks across 4 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 14 (Jewelry), Class 16 (Paper Goods), Class 28 (Toys & Sporting Goods). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Xingquan Wang's most well-known trademarks?
Xingquan Wang's registered trademark portfolio includes well-known marks such as JULBEAR, MARFOREVER, and ST NOVAELLE. These are among 3 currently registered trademarks in the portfolio.
What is Xingquan Wang's trademark registration success rate?
Xingquan Wang has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.